Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020;22(5):E352-357. doi: 10.1001/amajethics.2020.352. Case and Commentary May 2020 Sliding-Scale Shared Decision Making for Patients With Reduced Capacity Tim Lahey, MD, MMSc and Glyn Elwyn, MD, PhD, MSc Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity. AMA J Ethics. 2020;22(5):E358-364. doi: 10.1001/amajethics.2020.358. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary Apr 2021 是否应该为了推动其他自由而去限制某种自由? Katherine J. Feder (理学硕士), Janice I. Firn(理学博士、注册硕士社会工作者), and Ryan Stork(医学博士) AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305. Case and Commentary Apr 2021 ¿Debería limitarse un tipo de libertad a favor de otro? Katherine J. Feder, MS, Janice I. Firn, PhD, and Ryan Stork, MD AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305. Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608. Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020;22(5):E352-357. doi: 10.1001/amajethics.2020.352.
Case and Commentary May 2020 Sliding-Scale Shared Decision Making for Patients With Reduced Capacity Tim Lahey, MD, MMSc and Glyn Elwyn, MD, PhD, MSc Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity. AMA J Ethics. 2020;22(5):E358-364. doi: 10.1001/amajethics.2020.358.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary Apr 2021 是否应该为了推动其他自由而去限制某种自由? Katherine J. Feder (理学硕士), Janice I. Firn(理学博士、注册硕士社会工作者), and Ryan Stork(医学博士) AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305.
Case and Commentary Apr 2021 ¿Debería limitarse un tipo de libertad a favor de otro? Katherine J. Feder, MS, Janice I. Firn, PhD, and Ryan Stork, MD AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608.
Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608.